Rite Aid sponsors Dirt Track race on SPEED in May
CONCORD, N.C. Rite Aid may be making inroads with a younger demographic this year.
World Racing Group on Monday announced that SPEED will be the exclusive television partner for World of Outlaws racing in 2008, which includes coverage May 23 of the three-hour Rite Aid Outlaw Showdown broadcast live from The Dirt Track at Lowe’s Motor Speedway.
“The World of Outlaws broadcasts in 2007 showed us how exciting dirt track racing can be on television,” stated Rick Miner, SPEED senior vice president of Production and Network Operations. “The success of the World Finals show from The Dirt Track at Lowe’s Motor Speedway gave us a gameplan for ‘08, as part of that plan we will be treating the five new super-sized events just as we do any other major motorsports event on SPEED, which should significantly raise the profile of World of Outlaws racing.”
A return to SPEED in 2008 as the exclusive television outlet for World of Outlaws racing will bring consistency and awareness to the viewers.
“The broadcast agreement with SPEED continues the solid growth we realized in 2007,” stated World Racing Group chief executive officer Brian Carter. “The more than 75 million viewers on SPEED give our corporate partners … as well as our teams and our promoters, the greatest opportunity to reach our fans on a consistent basis. SPEED is the home for racing on television and we’re excited to again have the World of Outlaws on SPEED this season.”
Publix postpones Miracle Mile GreenWise opening
VERO BEACH, Fla. Publix Super Markets has placed on hold plans to open a Publix GreenWise organic grocer here, according to reports published Wednesday.
Plans for the Vero Beach store have slowed while the grocer focuses on opening its GreenWise concept in Boca Raton, Kim Jaeger, Publix spokeswoman, told Stuart News Group.
According to the Stuart News report, Publix had announced last September the first GreenWise Market would open on Miracle Mile in Vero Beach during the third quarter of 2008.
FDA approves new cancer drug from Cephalon
WASHINGTON The Food and Drug Administration ahs announced its approval of Cephalon’s new cancer drug, Treanda. This recent approval hopes to raise the company’s shares, which have fallen 29 percent since June, published reports claim.
Treanda, indicated for chronic lymphocytic leukemia, was granted priority review by the FDA. The FDA approval of Treanda will mark the first big step in the oncology department for Cephalon, which normally makes its sales on pain relievers and treatments for central-nervous-system disorders. According to reports, the approval of this drug will bring it close to competing with major drug companies.
The approval of Treanda not only is expected to raise the share price of the company, but will also pave the way for Cephalon to introduce more cancer-related drugs into the market. As a result, shares of Cephalon were up $2.79, or 4.7 percent, to $62.14.